SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000318771-08-000004
Filing Date
2008-02-26
Accepted
2008-02-25 21:48:04
Documents
8
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 GENETECH, INC. FORM 10-K FOR THE PERIOD ENDED 12/31/2007 form10-k_2007.htm 10-K 3059679
2 GENENTECH, INC. TAX REDUCTION INVESTMENT PLAN, AS AMENDED AND RESTATED dna-ex10_9.htm EX-10.9 577271
3 FORM OF GENENTECH, INC. 2004 EQUITY INCENTIVE PLAN NONQUALIFIED STOCK OPTION GRA dna-ex10_17.htm EX-10.17 78200
4 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dna-ex23_1.htm EX-23.1 10326
5 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULES 13A-14(A) AND 15D-14( dna-ex31_1.htm EX-31.1 11871
6 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULES 13A-14(A) AND 15D-14( dna-ex31_2.htm EX-31.2 11842
7 CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUANT T dna-ex32_1.htm EX-32.1 12274
8 PERFORMANCE GRAPH graph.jpg GRAPHIC 39161
  Complete submission text file 0000318771-08-000004.txt   3816953
Mailing Address 1 DNA WAY . SOUTH SAN FRANCISCO CA 94080
Business Address 1 DNA WAY SOUTH SAN FRANCISCO CA 94080 650-225-1000
GENENTECH INC (Filer) CIK: 0000318771 (see all company filings)

IRS No.: 942347624 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-09813 | Film No.: 08641170
SIC: 2834 Pharmaceutical Preparations